Celldex Therapeutics, Inc (CLDX)

Celldex Therapeutics (CLDX) stock hits a 52-week high driven by positive trial data and analyst upgrades. However, recent net losses and price volatility are causing concern among investors.

About Celldex Therapeutics, Inc

Celldex Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases.
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

• Celldex Therapeutics, Inc (CLDX) social dominance is up 309.09% from the previous week.
• Celldex Therapeutics, Inc (CLDX) Galaxy Score™ is up 31.43% from the previous week.
• Celldex Therapeutics, Inc (CLDX) creators is up 54.55% from the previous week.
• Celldex Therapeutics, Inc (CLDX) engagements is up 224.91% from the previous month.
• Celldex Therapeutics, Inc (CLDX) mentions is up 78.21% from the previous week.
• Celldex Therapeutics, Inc (CLDX) posts created is up 111.11% from the previous week.
• Celldex Therapeutics, Inc Price hit a 52-Week high of $32.60 for the hour

Price: $27

Price 24-Hour Time-Series Raw Data
The stock's price action is bullish, reaching a 52-week high due to positive trial data and analyst upgrades, as evidenced by the 16.78% gain over the past [--] days. However, concerns about recent net losses and price volatility are tempering this upward trend, reflected in the 24-hour gain of -1.24%.

24-Hour: -4.35% 7-Day: 14.5% 30-Day: 5.26%

1-Year High: $30 on 2026-02-17
1-Year Low: $15.10 on 2025-04-08

AltRank: [-----]

AltRank 24-Hour Time-Series Raw Data
Celldex Therapeutics, Inc (CLDX) is currently AltRank #1,064 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] [---]
[--] Month: [-----] [---]
[--] Months: [-----] +708
[--] Year: [-----] +175
1-Year High: [-----] on 2026-02-11
1-Year Low: [---] on 2025-12-21

Galaxy Score: [-----]

Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +11
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-04-11
1-Year Low: [--] on 2025-12-26

Engagements: [-----] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +93%
[--] Month: [-------] +225%
[--] Months: [-------] -31%
[--] Year: [---------] -11%
1-Year High: [-------] on 2025-08-20
1-Year Low: [--] on 2025-04-13

Engagements by network (24h): Reddit: [--] X: [-----]

Mentions: [--] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +78%
[--] Month: [---] +40%
[--] Months: [-----] -30%
[--] Year: [-----] +25%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-13

Mentions by network (24h): Reddit: [--] X: [--]

Creators: [--] (24h)

Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last [--] hours which is up 2.70% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +55%
[--] Month: [--] +13%
[--] Months: [---] -55%
[--] Year: [-----] +62%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-13

The most influential creators that mention Celldex Therapeutics, Inc in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[-----]
@BuyTheUgly	[--]	[--]	[--]	[--]
@RahulGandi86155	[--]	[--]	[--]	[--]
@DavidGanno28735	[--]	[--]	[--]	[--]
@hotterc45506	[--]	[--]	[--]	[--]
@hg19290	[--]	[--]	[--]	[--]
@doepke_michel	[--]	[-----]	[--]	[--]
@mariostario2019	[--]	[--]	[--]	[--]
@SMALLCAPSAXIS	[--]	[---]	[--]	[--]
@Rubi51030	[--]	[--]	[--]	[--]

View More

Sentiment: 78%

Sentiment 24-Hour Time-Series Raw Data
Current Value: 78%
Daily Average: 78%
[--] Week: 100% no change
[--] Month: 75% -17%
[--] Months: 75% +14%
[--] Year: 75% +15%
1-Year High: 100% on 2025-02-26
1-Year Low: 13% on 2025-11-29

Most Supportive Themes:

• Positive Trial Data: (40%) Recent positive trial data has been a significant driver for Celldex Therapeutics, boosting investor confidence and contributing to the stock's upward trend.
• Analyst Upgrades: (30%) Upgrades from financial analysts have further bolstered the positive sentiment surrounding Celldex Therapeutics, influencing its current market performance.

Most Critical Themes:

• Net Losses: (20%) Despite positive developments, Celldex Therapeutics has reported recent net losses, which are a point of concern for investors and may temper the stock's rally.
• Price Volatility: (10%) The stock has experienced notable price volatility, a factor that could introduce risk for investors and influence short-term trading strategies.

Social Dominance: 0.00502%

Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00502%
Daily Average: 0.00652%
[--] Week: 0.018% +0.014%
[--] Month: 0.013% +0.0089%
[--] Months: 0.013% -0.0019%
[--] Year: 0.013% +0.0049%
1-Year High: 0.034% on 2025-06-29
1-Year Low: 0.001% on 2025-12-25

Market Dominance: 0.00166%

Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00166%
Daily Average: 0%
1-Year High: 0.045% on 2025-03-31
1-Year Low: 0.00166% on 2025-04-09

Market Cap: $1,461,888,362

Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,461,888,362
Daily Average: $1,533,042,978
[--] Week: $1,528,337,833 -7.30%
[--] Month: $1,528,337,833 -10%
[--] Months: $1,528,337,833 +10%
[--] Year: $1,528,337,833 +1.50%
1-Year High: $1,980,194,236 on 2025-12-08
1-Year Low: $1,004,387,060 on 2025-04-08

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing